Zurueck zur Suche

Reporte zur Charge UJ536AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
IN 1 WA 1

VAERS 1062988

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ536AA

gering
Staat
IN
Alter
-
Geschlecht
M
Eingang
01.03.2021
Impfdatum
27.10.2020
Beginn
16.11.2020
Tage bis Beginn
20,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Medication error No adverse event

Symptomtext

patient had recieved two doses of 0.5ml Fluzone HD Quad vaccinations, in the left deltoid on 10/27/20 and 11/16/2020 with no reported adverse event; Initial information regarding an unsolicited valid non-serious case was received from other health care professional via Agency (Reference number- US-SANOFI-00479869) and transmitted to Sanofi on 17-Feb-2021 This case involves a 80 year old male patient who was administered of 0.5 ml QUADRIVALENT INFLUENZA VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] (lot number: UJ536AA,expiry date: 30-JUN-2021) via unknown route in left deltoid for prophylactic vaccination (extra dose administered) Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided. It was a case of an actual medication error due to extra dose administered (latency same day). The caller stated that patient PH had recieved two doses of 0.5ml Fluzone HD Quad vaccinations, in the left deltoid on 10/27/20 and 11/16/2020. Staff person had administered the last vaccination. At the time of report, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. There will be no information available on the batch number for this case.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1009849

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ536AA

gering
Staat
WA
Alter
72,0
Geschlecht
F
Eingang
07.02.2021
Impfdatum
23.10.2020
Beginn
24.10.2020
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Erythema Peripheral swelling Skin warm

Symptomtext

Patient reports her arm was hot and swollen and red for a duration of over 30 days after receiving the vaccine. Her primary care doctor has advised her not to get the 2nd dose.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Erythema
Hospital-Tage
-
Labordaten
unknown
Aktuelle Erkrankungen
unknown
Vorgeschichte
Glaucoma, cardiac disorder
Andere Medikamente
Nitroglycerin SL, Advair, prednisolone eye drops
Allergien
Oxycodone, sulfa antibiotics
Vorherige Impfungen
-